Clinical Management of Hyperkalemia

This publication has 85 references indexed in Scilit:

• Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate
  JAMA Internal Medicine, 2020
• Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age
  JAMA Internal Medicine, 2019
• Development and Validation of a Deep-Learning Model to Screen for Hyperkalemia From the Electrocardiogram
  JAMA Cardiology, 2019
• Long-Term Effects of Patiromer for Hyperkalaemia Treatment in Patients with Mild Heart Failure and Diabetic Nephropathy on Angiotensin-Converting Enzymes/Angiotensin Receptor Blockers: Results from AMETHYST-DN
  ESC Heart Failure, 2018
• Incidence, Predictors and Clinical Management of Hyperkalaemia in New Users of Mineralocorticoid Receptor Antagonists
  European Journal of Heart Failure, 2018
• Factors Associated with Underuse of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction: An Analysis of 11 215 Patients from the Swedish Heart Failure Registry
  European Journal of Heart Failure, 2018
• Potassium and the Use of Renin–Angiotensin–Aldosterone System Inhibitors in Heart Failure with Reduced Ejection Fraction: Data from BIOSTAT-CHF
  European Journal of Heart Failure, 2018
• Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease
  JAMA, 2015
• Effect of Sodium Zirconium Cyclosilicate on Potassium Lowering for 28 Days Among Outpatients With Hyperkalemia
  JAMA, 2014
• The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
  Archives of internal medicine (1960), 2009